Who has invested in BerGenBio?

Investinor are named among the investors backing BerGenBio.

BerGenBio Funding: $92M Raised, Series D (2016)

BerGenBio funding overview

BerGenBio is based in Bergen, Norway. BerGenBio has raised $92M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in March 2016. The round record for BerGenBio runs through 2016; nothing later has been disclosed. Investors on record include Investinor.

BerGenBio at a glance

Total raised: $92M
Latest round: Series D
Latest round date: March 2016
Headquarters: Bergen, Norway
Notable investors: Investinor

Frequently asked about BerGenBio funding

How much has BerGenBio raised?: BerGenBio has raised $92M in total disclosed funding across the rounds on record.
Who has invested in BerGenBio?: Investinor are named among the investors backing BerGenBio.
What was the latest BerGenBio funding round?: The most recent disclosed round is a Series D, announced in March 2016.
Where is BerGenBio based?: BerGenBio is based in Bergen, Norway.
When did BerGenBio last raise?: The last disclosed BerGenBio round closed in March 2016 at Series D.

Totals shown for BerGenBio aggregate every disclosed round on file. To see how that compares, browse the companies in Bergen and the investors behind them below.

BerGenBio Funding: $92M Raised, Series D (2016)

BerGenBio funding overview

BerGenBio at a glance

Frequently asked about BerGenBio funding

Companies related to BerGenBio (40)

Browse related funding lists (3)